Please use this identifier to cite or link to this item:
http://111.93.178.142:25000/jspui/handle/123456789/3093Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Parnika M. Sose | - |
| dc.date.accessioned | 2026-04-16T11:33:09Z | - |
| dc.date.available | 2026-04-16T11:33:09Z | - |
| dc.date.issued | 2026-04-16 | - |
| dc.identifier.uri | http://111.93.178.142:25000/jspui/handle/123456789/3093 | - |
| dc.description | Vol. 61, No. 11, p58 | en_US |
| dc.language.iso | en | en_US |
| dc.subject | Alzheimer's disease | en_US |
| dc.subject | feenofibrate | en_US |
| dc.subject | sildenafil | en_US |
| dc.subject | rivastigmine | en_US |
| dc.subject | aluminium chloride | en_US |
| dc.title | Assessment of the combination of fenofibrate and sildenafil in alzheimer's disease | en_US |
| dc.type | Other | en_US |
| Appears in Collections: | Vol61, No. 11, 2024 | |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.